tiprankstipranks
pc:baski

Basking Biosciences

Basking Biosciences is a clinical-stage biopharmaceutical company dedicated to changing the way potentially life-threatening blood clots are treated. Its novel therapies are designed to significantly improve safety and efficacy, broadening access to many more patients. The company's lead candidate, BB-031, is the first rapid-onset, short-acting thrombolytic therapy with a reversal agent, currently in development for the treatment of acute ischemic stroke.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$28M
Total Amount Raised$28M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$28M
Latest Funding Amount$28M
Latest Funding RoundInvestment
Latest Funding RoundInvestment
Post-Money Valuation
Post-Money Valuation

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Oct 22, 2025
Investment
$27.50M

Investors

Investor Name
Funding Round
Investment
Investment

Related News and Analysis